197 related articles for article (PubMed ID: 21393447)
1. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
[TBL] [Abstract][Full Text] [Related]
2. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas.
Chikatsu N; Fukumoto S; Takeuchi Y; Suzawa M; Obara T; Matsumoto T; Fujita T
J Biol Chem; 2000 Mar; 275(11):7553-7. PubMed ID: 10713061
[TBL] [Abstract][Full Text] [Related]
5. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
[TBL] [Abstract][Full Text] [Related]
7. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Eur J Endocrinol; 2003 Apr; 148(4):403-11. PubMed ID: 12656660
[TBL] [Abstract][Full Text] [Related]
8. Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization.
Pi M; Oakley RH; Gesty-Palmer D; Cruickshank RD; Spurney RF; Luttrell LM; Quarles LD
Mol Endocrinol; 2005 Apr; 19(4):1078-87. PubMed ID: 15637145
[TBL] [Abstract][Full Text] [Related]
9. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
12. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.
Avlani VA; Ma W; Mun HC; Leach K; Delbridge L; Christopoulos A; Conigrave AD
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1097-104. PubMed ID: 23531616
[TBL] [Abstract][Full Text] [Related]
14. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
[TBL] [Abstract][Full Text] [Related]
15. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
16. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
Goodman WG; Quarles LD
Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma.
Kaneko C; Mizunashi K; Tanaka M; Uzuki M; Kikuchi M; Sawai T; Goto MM
Calcif Tissue Int; 1999 Mar; 64(3):271-2. PubMed ID: 10024390
[TBL] [Abstract][Full Text] [Related]
18. [The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease].
Ilyicheva EA; Shurygina IA; Dremina NN; Bersenev GA; Grigoryev EG
Probl Endokrinol (Mosk); 2023 Jun; 69(3):24-34. PubMed ID: 37448244
[TBL] [Abstract][Full Text] [Related]
19. Adenomatous human parathyroid cells exhibit impaired sensitivity to L-amino acids.
Mun HC; Brennan SC; Delbridge L; Wilkinson M; Brown EM; Conigrave AD
J Clin Endocrinol Metab; 2009 Sep; 94(9):3567-74. PubMed ID: 19567535
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas.
Garner SC; Hinson TK; McCarty KS; Leight M; Leight GS; Quarles LD
Surgery; 1997 Dec; 122(6):1166-75. PubMed ID: 9426434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
